Benzonatate and Gastrointestinal motility disorder - a phase IV clinical study of FDA data


Gastrointestinal motility disorder is found among people who take Benzonatate, especially for people who are male, 50-59 old.

The phase IV clinical study analyzes which people take Benzonatate and have Gastrointestinal motility disorder. It is created by eHealthMe based on reports of 13,602 people who have side effects when taking Benzonatate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

13,602 people reported to have side effects when taking Benzonatate.
Among them, 10 people (0.07%) have Gastrointestinal motility disorder.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 14,180 Benzonatate users for its effectiveness, alternative drugs and more.

What is Gastrointestinal motility disorder?

Gastrointestinal motility disorder (abnormal intestinal contractions) is found to be associated with 1,049 drugs and 647 conditions by eHealthMe.

Number of Benzonatate and Gastrointestinal motility disorder reports submitted per year:

Could Benzonatate cause Gastrointestinal motility disorder?

Gender of people who have Gastrointestinal motility disorder when taking Benzonatate *:

  • female: 30 %
  • male: 70 %

Age of people who have Gastrointestinal motility disorder when taking Benzonatate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 11.11 %
  • 40-49: 0.0 %
  • 50-59: 66.67 %
  • 60+: 22.22 %

Common drugs people take besides Benzonatate *:

  1. Advil: 5 people, 50.00%
  2. Ampyra: 5 people, 50.00%
  3. Tysabri: 5 people, 50.00%
  4. Vitamin D3: 5 people, 50.00%
  5. Revatio: 5 people, 50.00%
  6. Promethazine: 4 people, 40.00%
  7. Belsomra: 4 people, 40.00%
  8. Ambien: 3 people, 30.00%
  9. Solu-Medrol: 3 people, 30.00%
  10. Cyanocobalamin: 2 people, 20.00%

Common side effects people have besides Gastrointestinal motility disorder *:

  1. Ageusia (loss of taste functions of the tongue): 6 people, 60.00%
  2. Constipation: 6 people, 60.00%
  3. Night Sweats (sweating in night): 5 people, 50.00%
  4. Weight Loss: 5 people, 50.00%
  5. Muscle Spasms (muscle contraction): 5 people, 50.00%
  6. Dry Mouth: 5 people, 50.00%
  7. Dizziness: 5 people, 50.00%
  8. Neuralgia (pain in one or more nerves): 5 people, 50.00%
  9. Neurological Symptom (symptoms of nervous system disease): 5 people, 50.00%
  10. Wheezing (a high-pitched whistling sound made while you breath): 5 people, 50.00%

Common conditions people have *:

  1. Gait Disturbance: 5 people, 50.00%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 40.00%
  3. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 30.00%
  4. Movement - Uncoordinated: 2 people, 20.00%
  5. Systemic Sclerosis Pulmonary (an autoimmune or connective tissue disease. it is characterized by thickening of the skin with involvement of lungs): 1 person, 10.00%
  6. Renal Cell Carcinoma (a kidney cancer): 1 person, 10.00%
  7. Pancreatic Carcinoma (pancreatic cancer): 1 person, 10.00%
  8. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 1 person, 10.00%
  9. Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 10.00%
  10. High Blood Pressure: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and have Gastrointestinal motility disorder?

Check whether Gastrointestinal motility disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Gastrointestinal motility disorder and when was it recovered:

Expand to all the drugs that have ingredients of benzonatate:

Alternative drugs to, pros and cons of Benzonatate:

Common Benzonatate side effects:

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gastrointestinal motility disorder treatments and more:

COVID vaccines that are related to Gastrointestinal motility disorder:

Common drugs associated with Gastrointestinal motility disorder:

All the drugs that are associated with Gastrointestinal motility disorder:

Common conditions associated with Gastrointestinal motility disorder:

All the conditions that are associated with Gastrointestinal motility disorder:

How the study uses the data?

The study uses data from the FDA. It is based on benzonatate (the active ingredients of Benzonatate) and Benzonatate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: